Literature DB >> 16321503

Detailed analysis of the methylation patterns of the KvDMR1 imprinting control region of human chromosome 11.

Linda Beatty1, Rosanna Weksberg, Paul D Sadowski.   

Abstract

The paternal repression of several genes in human chromosome 11p15.5 (mouse chromosome 7) is associated with paternal expression of a transcript called KCNQ1OT1 (also known as LIT1). This long transcript originates from a promoter that resides in a CpG island in intron 10 of the KCNQ1 gene and runs in an antisense orientation to the direction of the coding KCNQ1 transcript. The CpG island is maternally methylated but paternally nonmethylated. The CpG island loses its maternal methylation in over 50% of cases of Beckwith-Wiedemann syndrome who lack uniparental disomy. This loss is usually accompanied by biallelic expression of the KCNQ1OT1 transcript. We have examined the methylation status of this CpG island in somatic cell hybrids and diploid lymphoblasts using Southern hybridization and bisulfite sequencing techniques. We find that the maternal copy of the CpG island is methylated at all CpGs examined within the CpG island and uniformly paternally unmethylated. In addition, in BWS patients who have lost methylation of the CpG island, this loss occurs throughout the CpG island. Finally, we find that there is a switch in methylation patterns outside the CpG island from maternal methylation within the island to predominantly paternal methylation at sites flanking the CpG island.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16321503     DOI: 10.1016/j.ygeno.2005.05.015

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  8 in total

1.  Two distinct mechanisms of silencing by the KvDMR1 imprinting control region.

Authors:  Jong-Yeon Shin; Galina V Fitzpatrick; Michael J Higgins
Journal:  EMBO J       Date:  2007-12-13       Impact factor: 11.598

Review 2.  The role of imprinted genes in fetal growth abnormalities.

Authors:  Jorge A Piedrahita
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-06-06

3.  The role of CTCF in the organization of the centromeric 11p15 imprinted domain interactome.

Authors:  Natali S Sobel Naveh; Daniel F Deegan; Jacklyn Huhn; Emily Traxler; Yemin Lan; Rosanna Weksberg; Arupa Ganguly; Nora Engel; Jennifer M Kalish
Journal:  Nucleic Acids Res       Date:  2021-06-21       Impact factor: 16.971

4.  Extensive epigenetic reprogramming in human somatic tissues between fetus and adult.

Authors:  Ryan Kc Yuen; Sarah Ma Neumann; Alexandra K Fok; Maria S Peñaherrera; Deborah E McFadden; Wendy P Robinson; Michael S Kobor
Journal:  Epigenetics Chromatin       Date:  2011-05-05       Impact factor: 4.954

5.  11p15 DNA-methylation analysis in monozygotic twins with discordant intrauterine development due to severe twin-to-twin transfusion syndrome.

Authors:  Felix Schreiner; Bettina Gohlke; Sonja Stutte; Peter Bartmann; Kurt Hecher; Johannes Oldenburg; Osman El-Maarri; Joachim Woelfle
Journal:  Clin Epigenetics       Date:  2014-03-28       Impact factor: 6.551

6.  Expression of KCNQ1OT1, CDKN1C, H19, and PLAGL1 and the methylation patterns at the KvDMR1 and H19/IGF2 imprinting control regions is conserved between human and bovine.

Authors:  Katherine Marie Robbins; Zhiyuan Chen; Kevin Dale Wells; Rocío Melissa Rivera
Journal:  J Biomed Sci       Date:  2012-11-15       Impact factor: 8.410

7.  Methylation of Cdkn1c may be involved in the regulation of tooth development through cell cycle inhibition.

Authors:  Qiulan Li; Yue Guo; Mianfeng Yao; Jun Li; Yingyi Chen; Qiong Liu; Yun Chen; Yuanyuan Zeng; Bin Ji; Yunzhi Feng
Journal:  J Mol Histol       Date:  2018-07-16       Impact factor: 2.611

8.  Differential methylation of the type 2 diabetes susceptibility locus KCNQ1 is associated with insulin sensitivity and is predicted by CpG site specific genetic variation.

Authors:  Ushma J Shah; Weijia Xie; Allan Flyvbjerg; John J Nolan; Kurt Højlund; Mark Walker; Caroline L Relton; Hannah R Elliott
Journal:  Diabetes Res Clin Pract       Date:  2019-01-11       Impact factor: 5.602

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.